China Life Sciences - December 2011

more+
less-
more+
less-
Explore:  China Life Sciences

In this issue: Investor Q&A; Implications of the Leahy-Smith America Invents Act for Chinese Life Science Companies; Frequent Issues Arising in Acquisitions of China Life Sciences Targets; and Key Regulatory Development.

Welcome to the inaugural issue of our China Life Sciences Newsletter, a periodic update on key developments, companies and people in the dynamic China life sciences industry. The goal of the newsletter is to provide companies, entrepreneurs and investors with useful information on the issues and opportunities most relevant to China life sciences businesses.

Our issue opens with an Investor Q&A piece with Dr. Leon Chen of Fidelity Growth Partners Asia. Dr. Chen’s experience spans the research laboratory, management consulting, and most recently, life sciences venture capital industries. Dr. Chen reviews notable trends and opportunities in the med device sector in China. Next is an article by a Morrison & Foerster patent partner Peng Chen addressing implications of the Leahy-Smith America Invents Act specifically for Chinese life science companies, including the need to reevaluate patent application filing strategies and policies regarding public disclosure of inventions in view of the shift to first-to-file, and amendments to the test for what is considered prior art under U.S. patent law. Finally, we also feature in this inaugural issue an article highlighting key points to consider when acquiring a Chinese life sciences company, and a brief note on regulatory developments of interest.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  China, Life Sciences

Published In: Administrative Agency Updates, Business Organization Updates, Intellectual Property Updates, Mergers & Acquisitions Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »